Notice of National Heart, Lung, and Blood Institute (NHLBI) Participation in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)"

Notice Number: NOT-HL-14-220

Key Dates
Release Date: March 26, 2014

Related Announcements
RFA-HG-14-020

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)."

The following sections of RFA-HG-14-020 have been updated to reflect NHLBI's participation in this funding opportunity announcement.

Part 1. Overview Information

Components of Participating Organizations
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Library of Medicine (NLM)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Office of Strategic Coordination (Common Fund)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Numbers
93.172; 93.846; 93.242; 93.853; 93.173; 93.856; 93.855; 93.879; 93.310; 93.286; 93.279; 93.393, 93.394; 93.395; 93.396; 93.399, 93.837, 93.838, 93.839, 93.233.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Jennie Larkin, Ph.D.
National Heart, Lung and Blood Institute (NHLBI)
Telephone: 301-435-0513
Email: [email protected]